Tobacco control research scientific and technical services support contract - IDIQ

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N91022D00010
Awardee
Awarding agency
Task orders
4 $4,850,724 obligated

Award facts

Opportunity
Combined order value
  • $4,850,724 Current, with exercised options
  • $7,265,696 Potential, with all options
Last date to order 84% complete
IDV ceiling 32% used
$15,000,000.00
Maximum order
$15,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Cancer Institute (NCI), part of the National Institutes of Health, awarded a $15 million single-award Indefinite Delivery Contract (IDC) to Strategix Management LLC, a certified 8(a) small disadvantaged business, for scientific and technical services support. Under this IDC, NCI has issued two task orders to Strategix Management:

  1. A $6,391,216 cost-plus-fixed-fee delivery order for core support activities, including scientific writing, technical, and logistical support services for NCI's Tobacco Control Research Branch (TCRB) and Division of Cancer Control and Population Sciences (DCCPS). This 5-year contract aims to support NCI's mission to develop and disseminate tobacco research-related materials, conduct meetings, and generally support TCRB's internal and external efforts.

  2. A $1,989,220 cost-plus-fixed-fee delivery order for the development, production, and dissemination of NCI tobacco control monographs over a 3.5-year period. This effort will also be performed in Washington, D.C.

The original pre-solicitation notice indicated that NCI intended to issue a competitive 8(a) set-aside contract for these scientific, technical, and logistical support services. Strategix Management, as an 8(a) certified, minority-owned small disadvantaged business, was awarded this IDC to provide comprehensive support to NCI's tobacco control research initiatives.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91022D00010?

75N91022D00010 was awarded to Strategix Management LLC by National Cancer Institute (National Institutes of Health) on August 1, 2022.

How much is contract 75N91022D00010 worth?

Orders under 75N91022D00010 have obligated $4,850,724. Their combined potential value, with all options, is $7,265,696. 75N91022D00010's own ceiling is $15,000,000. A single order can be worth up to $15,000,000.

How many orders have been placed under contract 75N91022D00010?

4 orders have been placed under 75N91022D00010, the latest on September 18, 2024.

Who can order from contract 75N91022D00010?

75N91022D00010 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N91022D00010 competed?

The extent of competition for 75N91022D00010 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Competitive 8(a).

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV